EP 4313141 A1 20240207 - NOVEL USE OF AN IMMUNOGENIC OR VACCINAL COMPOSITION AGAINST COVID-19
Title (en)
NOVEL USE OF AN IMMUNOGENIC OR VACCINAL COMPOSITION AGAINST COVID-19
Title (de)
NEUE VERWENDUNG EINER IMMUNOGENEN ODER VAKZINALEN ZUSAMMENSETZUNG GEGEN COVID-19
Title (fr)
NOUVELLE APPLICATION D'UNE COMPOSITION IMMUNOGENE OU VACCINALE CONTRE LA COVID-19
Publication
Application
Priority
- DE 102021001467 A 20210322
- EP 21180476 A 20210618
- EP 22152573 A 20220120
- EP 2022057548 W 20220322
Abstract (en)
[origin: WO2022200384A1] The present invention relates to an anti-SARS-CoV-2 immunogenic or vaccinal composition for use in the treatment of COVID-19, the composition being characterised in that it is administered to the ocular mucosa and/or the urogenital mucosa.
IPC 8 full level
A61K 39/215 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP US)
A61K 9/0048 (2013.01 - US); A61K 39/215 (2013.01 - EP US); A61P 31/14 (2018.01 - US); A61K 2039/541 (2013.01 - EP US); A61K 2039/542 (2013.01 - EP); A61K 2039/543 (2013.01 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022200384 A1 20220929; AU 2022245195 A1 20230921; BR 112023019270 A2 20231205; EP 4313141 A1 20240207; MX 2023011173 A 20240104; US 2024165219 A1 20240523
DOCDB simple family (application)
EP 2022057548 W 20220322; AU 2022245195 A 20220322; BR 112023019270 A 20220322; EP 22717147 A 20220322; MX 2023011173 A 20220322; US 202218283061 A 20220322